Oklahoma Doctors Have Tremendous Success in Treating Nursing Home Covid Patients with Ivermectin

The Gateway Pundit previously reported that a new international report of 64 studies shows Ivermectin has an 86% success rate as prophylaxis and a 67% success rate in the early treatment of coronavirus.

Now, two Oklahoma doctors, Dr. John Sutton and Dr. David Jayne shared their stories about the use of Ivermectin as a treatment for their patients with COVID-19.

Dr. John Sutton is an Internal Medicine Specialist in Woodward, Oklahoma, and has over 38 years of experience in the medical field. He served three nursing homes in Woodward and Dewey county that experienced a COVID-19 outbreak.  And Dr. Jayne works in Edmond, OK, and specializes in Family Medicine and Preventive Care.

The government’s intervention in treating COVID-19 patients greatly concerns the two doctors.

“The government is trying to overreach their authority… Doctors have been pretty autonomous ever since there was the first doctor. The doctor could think for himself and do what he thought was right for a patient. And I don’t think the government ought to be telling doctors how to practice medicine.” — Dr. John Sutton

“I treat them and guess what? They get better. I can’t stand back and do nothing when I know I can help people.” —Dr. David Jayne

Oklahoma Council of Public Affairs report:

All three nursing homes served by Sutton have experienced COVID-19 outbreaks. The first home experienced an outbreak before vaccines were widely available and before “ivermectin was even in the discussion,” Sutton said.

That nursing home experienced a 30-percent mortality rate among those who contracted the virus, he said.

By the time an outbreak occurred at the second nursing home, both Ivermectin and monoclonal antibodies were known treatments and were provided to residents. Sutton also ordered that all residents be provided Ivermectin “whether they had the disease or not.”

Of 56 residents in that home, only one died from COVID.

“The thing that was different from the first nursing home was the monoclonal antibodies and the ivermectin,” Sutton said.

When the third nursing home had an outbreak, a similar course of treatment was pursued. Out of 75 residents, only one died.

Read the Whole Article